Results 111 to 120 of about 4,961 (248)
International Journal of Laboratory Hematology, Volume 46, Issue 1, Page 120-127, February 2024.Abstract Introduction The knowledge of dabigatran levels is helpful for decision‐making in specific situations such as urgent surgery or when the question of reversal arises (uncontrolled bleeding, eligibility for thrombolysis). However, a limited number of observational studies are available regarding comparisons between quantification methods.
Ambre de Fautereau‐Vassel +8 more
wiley +1 more source
Российский кардиологический журнал, 2020 Aim. To study the characteristics of direct oral anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease (COPD) and atrial fibrillation.
L. A. Shpagina +10 more
doaj +1 more source
Stroke Research and Treatment, Volume 2024, Issue 1, 2024.Introduction. Direct oral anticoagulants (DOAC) are the first‐line treatment for primary and secondary acute ischaemic stroke (AIS) prevention in patients with nonvalvular atrial fibrillation (NVAF), but a significant percentage of patients develop AIS despite being treated with DOAC.
Katarzyna Sawczyńska +13 more
wiley +1 more source
Performance of idarucizumab as antidote of dabigatran in daily clinical practice
EP Europace, 2018 Because practice-based data on the usage of idarucizumab for urgent dabigatran reversal is unavailable, we evaluated the appropriateness of idarucizumab usage, its haemostatic effectiveness and clinical outcomes.An observational cohort study was performed including consecutive patients who were treated with idarucizumab between 2016 and 2018 ...
Wall, S.J. van der +11 more
openaire +7 more sources
Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment
Journal of the American College of Cardiology, 2019 Dabigatran and idarucizumab, its reversal agent, are renally cleared.The purpose of this study was to determine the extent of reversal and outcomes according to baseline renal function in dabigatran-treated nondialysis patients receiving idarucizumab.In 503 patients in RE-VERSE AD (Reversal of Effects of Idarucizumab in Patients on Active Dabigatran ...
Charles V. Pollack +8 more
openaire +3 more sources
Fibrilación auricular en los servicios de urgencias hospitalarias [PDF]
, 2016 La fibrilación auricular (FA) es la arritmia cardíaca sostenida más frecuente en la población. Es una enfermedad grave y es un factor predictivo independiente de mortalidad, asociando un riesgo de ictus 5 veces superior a la población general.
García Palacios, José David
core
Outcome of intracerebral hemorrhage associated with different oral anticoagulants [PDF]
, 2017 Objective: In an international collaborative multicenter pooled analysis, we compared mortality, functional outcome, intracerebral hemorrhage (ICH) volume, and hematoma expansion (HE) between non-vitamin K antagonist oral anticoagulation-related ICH ...
Ambler, Gareth +31 more
core +4 more sources
Direct oral anticoagulants: first airbag
Медицинский совет, 2019 The safety profile of oral anticoagulants (DOACs) was confirmed in the large-scale studies, the increased risk of hemorrhagic events does still exist, which may be caused by the nature of the patient’s concomitant pathology, the resulting injury or the ...
A. N. Sokolova, A. I. Skripka
doaj +1 more source
Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs [PDF]
, 2014 Markus Honickel +5 more
openalex +1 more source
Perspectivas clínicas del manejo de la hemorragia en el paciente tratado con anticoagulante oral: estudio DECOVER [PDF]
, 2018 Objetivo. Evaluar el grado de acuerdo entre hematólogos y urgenciólogos respecto a las mejores prácticas para el manejo de hemorragias y la reversión de la anticoagulación oral. Método.
Camats, Míriam +12 more
core